métodos estadísticos en el trasplante renal - Roche Trasplantes

More documents

Recommendations

Info

MÉTODOS ESTADÍSTICOS EN EL TRASPLANTE RENAL23. Gill JS, Abichandani R, Kausz AT, Pereira BJ. Mortality after kidney transplant failure:the impact of non-immunologic factors. Kidney International 2002; 62(5):1875-83.24. Matas AJ, Gillingham KJ, Sutherland DER. Half-life and risk factors for kidney transplantoutcome. Importance of death with function. Transplantation 1993; 55: 757-61.25. Tarshish P, Bernstein J, Tobin JN, Edelmann CM. Treatment of mesangiocapillaryglomerulonephritis with alternate-day prednisone, A report of International Study ofKidney Diseases in Chlidren. Pediatr Nephrol 1992; 6: 120-3.26. Hariharan S, Jonson CP, Bersnahan BA, Taranto SE, McIntosh MJ, Stablein D.Improved Graft Survival after Renal Transplantation in the United States 1988 to1996. New Eng J Med 2000; 342: 605-12.27. Wing AJ, D’Amaro J, Lamm LU, Selwood N. Evolving methodologies in computerizedEuropean Registries. Kidney International 1983; 24: 507- 15.28. Gjertson DW, Terasaki PI. The large center variation in half-life of kidney transplantation.Transplantation 1992; 53: 357-62.29. Thorogoog J, Houwelingen JC, Persijn GG, Zantvoort FA, Schreuder GM, Van RoodJJ. Prognostic indices to predict survival of first and second renal allografts.Transplantation 1991; 831-6.30. Guttmann RD. The Graft Survival Curve: Ideology and rhetoric. Trasnsplant. Proc1992; 24: 2407-10.31. Fernández M, Abraira V, Quereda C, Ortuño J. Curvas de supervivencia y modelosde regresión: errores y aciertos en la metodología de aplicación. Nefrología 1996;26: 383-90.32. Clark TG, Bradburn MJ, Love SB, Altman DG. Survival Analysis. Basic concepts andfirst analyses. Br J Cancer 2003; 89: 232-8.33. Van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT.How to adjust for comorbidity in survival studies in ESRD patients: a comparison ofdifferent indices. Am J Kidney Dis. 40(1): 82-8.34. Charlson M, Szatrowski TP, Petreson P, Gold J. Validation of a CombinedComorbidity Index. J Clin Epidemiol 1994; 47: 1245-51.35. Hammelgan BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson Comorbidityindex for use in patients with ESRD. Am J Kidney Dis 2003; 42: 125-32.36. Van Dick PCW, Jager KJ, de Charro F, Collart R, Cornet FW, Dekker W, Grönhagen-Riska, Kramar R, Leivestad T, Simpson K, Briggs JD. Renal replacement therapy inEurope: the results of a colaborative effort by the ERA-EDTA registry and six nationalor regional registries. Nephrol Dial Trasplant 2001; 16: 1120-30.37. ERA-EDTA Registry. www.era-edta-reg.org38. Researcher´s Guide. www//usrds.org/research.htm39. Mc Donald SP, Russ GR, Kerr PG, Collins JF. ESRD in Australia and New Zealand atthe end of Milenium: a report from ANZDATA registry. Am J Kidney Dis 2002; 40:1122-31.132
CURVAS DE VIDA Y SUPERVIVENCIA40. Anzdata Annual Reports. www.anzdata.org.au/anzdata/AnzdataReport41. Wolfe RA, Strawderman RL. Logical and Statistical Fallacies in the Use of CoxRegression Models. Am J Kidney Dis 1996; 27: 124-9.42. Matas AJ, Gillingham KJ, Sutherland DER. Half-life and risk factors for kidney transplantoutcome. Importance of death with function. Transplantation 1993; 55: 757-60.43. Hutchinson TA, Thomas DC, Lemieux JC, Harvey CE. Prognostically controlled comparisonof dialysis and renal transplantation. Kidney International 1984; 26: 44-51.44. Port FK, Wolfe RA, Mauger EA, Berling DP, Jiang K. Comparison of survival probabilitiesfor dialysis patients vs. cadaveric transplantation. JAMA 1993; 270: 1339-43.45. Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Aggoda LYC, Held PJ, PortFK. Comparison of mortality in all patients on dialysis awaiting transplantation andrecipients of a first cadaveric trasplant. New E J Med 1999; 341: 1725-30.46. Clark TG, Altman DG, De Stavola BL. Quantification of the completeness of followup.Lancet 2002; 359: 1309-10.47. CASP España (CASPe). www.redcaspe.org48. Lupacis A, Wells G, Richardson WS, Tugwell P. User´s Guides to the medical literature;how to use an article about prognosis. JAMA 1994; 272: 234-7.133
Page 1 and 2:
B i b l i o t e c a d eT R A S P L
Page 3 and 4:
DRUGEdificio Vértice Antonio Lópe
Page 6:
Electronic Control Device Research
Page 10 and 11:
MÉTODOS ESTADÍSTICOS EN EL TRASPL
Page 12 and 13:
Page 14 and 15:
Page 16 and 17:
Page 18 and 19:
Page 20 and 21:
Page 22 and 23:
Page 24 and 25:
Page 26 and 27:
Page 29:
ESTADÍSTICA EN BIOMEDICINA: UNA HE
Page 32 and 33:
Page 34 and 35:
Page 36 and 37:
Page 38 and 39:
Page 40 and 41:
Page 42 and 43:
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 50 and 51:
Page 52 and 53:
Page 54 and 55:
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
EL CONCEPTO DE SEMIVIDACOMO PREDICT
Page 68 and 69:
EL CONCEPTO SEMIVIDA COMO PREDICTOR
Page 70 and 71:
Page 72 and 73:
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
Page 82 and 83:
Page 84 and 85:
Page 86 and 87:
Page 88 and 89:
Page 90 and 91:
Page 92 and 93:
Page 94 and 95: MÉTODOS ESTADÍSTICOS EN EL TRASPL
Page 146 and 147: DE LAS BASES DE DATOSA LOS PROGRAMA
Page 148 and 149: DE LAS BASES DE DATOS A LOS PROGRAM
Page 160 and 161: RESULTADOS DEL TRASPLANTERENAL: ENS
Page 162 and 163: RESULTADOS DEL TRASPLANTE RENAL: EN
Page 194:
RESULTADOS DEL TRASPLANTE RENAL: EN
show all

métodos estadísticos en el trasplante renal - Roche Trasplantes

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?